Trueblood Wealth Management’s Linde LIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.22M Buy
4,487
+18
+0.4% +$8.49K 0.87% 22
2025
Q4
$1.91M Buy
4,469
+69
+2% +$29.6K 0.74% 34
2025
Q3
$2.09M Buy
4,400
+98
+2% +$46.4K 0.82% 22
2025
Q2
$2.02M Buy
4,302
+239
+6% +$109K 0.84% 23
2025
Q1
$1.89M Buy
4,063
+305
+8% +$137K 0.88% 22
2024
Q4
$1.57M Buy
3,758
+83
+2% +$37.8K 0.78% 25
2024
Q3
$1.75M Buy
3,675
+54
+1% +$24.6K 0.88% 23
2024
Q2
$1.59M Buy
3,621
+31
+0.9% +$13.6K 0.9% 24
2024
Q1
$1.67M Buy
3,590
+120
+3% +$52K 0.95% 21
2023
Q4
$1.43M Buy
+3,470
New +$1.37M 0.89% 25

Other funds holding LIN

Trueblood Wealth Management's LIN Position: Q1 2026 in Review

Trueblood Wealth Management increased its Linde (LIN) stake by 0.4% in Q1 2026, buying an estimated $8.49K and bringing the position to 4,487 shares worth $2.22M. The position accounts for 0.87% of the portfolio, ranked #22.

Trueblood Wealth Management first reported a position in LIN in Q4 2023 and has held it in 10 quarters since. 2,267 funds tracked by Wall St. Rank hold LIN as of Q1 2026.

  • Trueblood Wealth Management held 4,487 shares of Linde worth $2.22M as of Q1 2026.
  • Trueblood Wealth Management bought 18 Linde shares in Q1 2026, an estimated $8.49K.
  • Linde made up 0.87% of Trueblood Wealth Management's portfolio in Q1 2026, its #22 holding.
  • Trueblood Wealth Management first reported a position in Linde in Q4 2023 and has held it in 10 quarters since.
  • 2,267 funds tracked by Wall St. Rank held Linde as of Q1 2026.

Based on Trueblood Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.